S&P 500 Healthcare Sector SEC Filings — December 22, 2025

23-12-2025

Integral Ad Science Holding Corp. filed an 8-K on December 23, 2025, disclosing entry/termination of material agreements, completion of acquisition/disposition, change of control, delisting notice, security holder rights changes, and governance updates. No specific parties, valuation, terms, or quantitative data provided in filing summary. Indicates likely take-private transaction or merger completion with delisting.

• ·Deal completion (Item 2.01) and change of control (Item 5.01) confirmed.
• ·Delisting notice (Item 3.01) and modifications to security holder rights (Item 3.03).
• ·New financial obligations (Item 2.03) and board/officer changes (Item 5.02).

23-12-2025

ENB Financial Corp filed an 8-K on December 23, 2025, disclosing Item 8.01 Other Events. No specific details on the event, transaction value, or financial impacts are provided in the filing summary. Analysis limited to metadata; core event NOT_DISCLOSED.

• ·Single-item 8-K filing under Item 8.01 (Other Events); voluntary disclosure.
• ·No quantitative data (e.g., transaction value, share count, financial metrics) extracted: all NOT_DISCLOSED.
• ·Timing: Filed same day as event date; compliance with 4-business-day window presumed but unconfirmed.

23-12-2025

Coca-Cola Europacific Partners plc reported weekly share repurchases under its EUR 1 billion buyback programme announced on February 14, 2025, purchasing 37,147 shares on December 16, 36,922 on December 17, 36,829 on December 18, and additional shares on December 22 on US trading venues at average prices around USD 91.94-92.65. All repurchased ordinary shares will be cancelled. The company announced the completion of the share buyback programme on December 22, 2025.

• ·Repurchased 37,147 shares on Dec 16 at VWAP USD 91.96 (high USD 92.50, low USD 91.32)
• ·Repurchased 36,922 shares on Dec 17 at VWAP USD 92.65 (high USD 93.19, low USD 92.27)
• ·Repurchased 36,829 shares on Dec 18 at VWAP USD 91.94 (high USD 92.38, low USD 91.54)
• ·Completion of EUR 1 billion share buyback programme announced Dec 22, 2025
• ·All purchases on US venues; repurchased shares to be cancelled, signaling capital return to shareholders

23-12-2025

Peapack Gladstone Financial Corp filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-330703, size 190 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer's name, position, reason for change, or compensatory arrangements are provided.

23-12-2025

Zivo Bioscience, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001654954-25-014296, Size: 288 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer, position, reason, or quantitative data are provided.

23-12-2025

HCI Group, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-330946, Size: 370 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing as a Material Event. No specific details, transaction values, personnel names, or quantitative impacts are disclosed in the provided summary.

23-12-2025

KeyCorp filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-331038, Size: 229 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

23-12-2025

Arcadia Biosciences, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-331009, Size: 180 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No details on specific matters voted on, outcomes, or any numerical data are disclosed in the provided filing summary. Sector not specified.

23-12-2025

USCB Financial Holdings, Inc. disclosed an officer change via Form 8-K filed on December 23, 2025, under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the filing summary. AccNo: 0000927089-25-000220; File size: 235 KB.

23-12-2025

Milestone Scientific Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001493152-25-029067, Size: 240 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No details on specific matters voted on, vote results, or any numerical data are disclosed in the provided filing summary. This is a single-item mandatory disclosure following a shareholder meeting.

23-12-2025

Skye Bioscience, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001628280-25-058729, Size: 142 KB), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's parties, terms, value, or strategic context are disclosed. Sector not specified.

23-12-2025

National CineMedia, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-330847, Size: 547 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.

23-12-2025

CID Holdco, Inc. disclosed an officer change event on December 23, 2025, via SEC Form 8-K under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons for change, or compensatory arrangements are provided in the filing summary. Filing accession number: 0001213900-25-125321, size: 250 KB.

23-12-2025

Six Flags Entertainment Corporation/NEW filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-330990, Size: 130 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names, reasons for change, or any quantitative data are provided in the available information. Sector is not specified.

23-12-2025

GCI Liberty, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001104659-25-124246, Size: 249 KB), disclosing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are specified in the filing summary. This appears to be a voluntary disclosure under Regulation FD with attached exhibits.

23-12-2025

CVB Financial Corp filed a Form 8-K on December 23, 2025 (AccNo: 0001193125-25-331051, Size: 1 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, transaction values, or financial metrics are disclosed in the provided filing summary. Sector not specified.

23-12-2025

Citius Pharmaceuticals, Inc. filed an 8-K on December 23, 2025 (AccNo: 0001213900-25-125413, size: 306 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.

23-12-2025

McEwen Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001104659-25-124286, Size: 364 KB), disclosing under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specifics are provided in the filing summary. Sector is not specified.

23-12-2025

Jupiter Neurosciences, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001493152-25-029124, Size: 226 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses a significant transaction involving a new agreement, financial obligation, and unregistered equity sales, but no specific details, dollar values, share counts, parties, or financial metrics are provided in the summary. Sector is not specified.

23-12-2025

Citius Oncology, Inc. filed a Form 8-K on December 23, 2025 (AccNo: 0001213900-25-125418, Size: 296 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure for a company in an unspecified sector. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.

23-12-2025

Burke & Herbert Financial Services Corp. filed an 8-K on 2025-12-23 disclosing an officer change under Item 5.02 (Departure/Election/Appointment of Officers or Compensatory Arrangements) and exhibits under Item 9.01. No specific details on position affected, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; all other facts NOT_DISCLOSED.

• ·Item 5.02 triggered: Officer change or compensatory arrangement
• ·Filed timely per SEC 8-K requirements (within 4 business days)
• ·No names, positions, reasons, or financial metrics disclosed

23-12-2025

Cassava Sciences Inc filed an 8-K on December 23, 2025 (AccNo: 0001437749-25-038605), reporting under Item 1.01 entry into a Material Definitive Agreement. No details on the agreement's nature, parties, value, or terms are disclosed in the provided summary. This is a mandatory disclosure of a material event.

• ·8-K Item 1.01: Entry into a Material Definitive Agreement
• ·Single-item filing
• ·Filed 2025-12-23; timing compliance NOT_DISCLOSED

23-12-2025

News Corp filed a Form 8-K on December 23, 2025, reporting Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the core event, transaction, or exhibits are disclosed in the provided summary. This is a multi-item filing with limited information available for analysis.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Filing Date: 2025-12-23; timing compliance cannot be assessed without event date
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

23-12-2025

Zicix Corp filed a Form 8-K on December 23, 2025, under Item 5.02 disclosing an unspecified officer change involving departure, election, appointment, or compensatory arrangements. No details on the key position, individual names, appointment/resignation status, reasons, or quantitative data are provided. Sector is not specified, limiting assessment of implications.

• ·Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
• ·Filed: 2025-12-23, AccNo: 0001683168-25-009312
• ·No quantitative data (Transaction Value: NOT_DISCLOSED, Share Count: NOT_DISCLOSED, Percentage Changes: NOT_DISCLOSED, Financial Metrics: NOT_DISCLOSED)